8 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Fremanezumab for ... to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
#PrimaryCare #EM ... #IM #Differential ... Lightheadedness #Table ... #NEJM
Six Trials of Patent Foramen Ovale Closure for Stroke with Results Published in the Journal. #EBM
#EBM #Neuro #Cardiology ... EvidenceSummary #Table ... #NEJM
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease (COMPASS) #EBM #Cardiology #Rivaroxaban #Aspirin #COMPASS #VisualAbstract
without Aspirin in Stable ... Disease (COMPASS) #EBM ... #Cardiology #Rivaroxaban ... VisualAbstract #NEJM
Table of Common Rate Control Agents via AHA/ACC/HRS Guidelines #Management #Pharm #EM #IM #Cardiology #Afib #Common
Table of Common ... Management #Pharm #EM ... #IM #Cardiology ... #RateControl #Table
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI trial) - Shown is
warfarin (Panel A) #EBM ... #Cardiology #IM ... AtrialFibrillation #NEJM